What Is Peptide Therapy?
Peptide therapy refers to the medical use of specific peptides — short chains of amino acids — to treat, manage, or optimize health conditions. It’s one of the fastest-growing areas of functional, regenerative, and anti-aging medicine, practiced by an expanding network of physicians, naturopathic doctors, and advanced practice providers who prescribe targeted peptides for specific therapeutic outcomes.
The concept isn’t new. Insulin — a peptide hormone — has been used therapeutically since 1922. Over 100 peptide drugs are now FDA-approved for conditions ranging from diabetes to cancer to sexual dysfunction. What’s changed in the last decade is the dramatic expansion of compounded peptide therapy: physicians prescribing specific peptides — often prepared by specialty pharmacies — for targeted applications like tissue healing, growth hormone optimization, and cognitive enhancement.
How Peptide Therapy Works
Peptides work as biological keys that fit specific cellular locks (receptors). When a peptide binds to its target receptor, it triggers a cascade of intracellular events that produce a measurable biological response — whether that’s releasing growth hormone, accelerating tissue repair, reducing appetite, or modulating the immune system.
This receptor specificity is the fundamental advantage of peptide therapy over many conventional drugs. A growth hormone secretagogue like Ipamorelin stimulates the pituitary gland to release growth hormone in a natural pulsatile pattern — without the side effects of directly injecting synthetic HGH. A healing peptide like BPC-157 promotes angiogenesis and tissue repair through specific growth factor pathways without broadly suppressing inflammation.
Routes of Administration
Subcutaneous injection is the most common route, offering 90-100% bioavailability. Injections are typically self-administered using small insulin syringes. Oral peptides work for some compounds — collagen peptides and BPC-157 have demonstrated meaningful oral absorption. Nasal sprays are used for neuropeptides that need to cross the blood-brain barrier. Topical application works for certain skin-targeting peptides like GHK-Cu.
Clinical Applications
Peptide therapy spans a remarkably wide range of clinical applications. Here are the major categories, the peptides used, and the evidence level for each.
| Application | Key Peptides | Evidence |
|---|---|---|
| Tissue Healing & Recovery | BPC-157, TB-500, GHK-Cu | Strong preclinical; extensive clinical use |
| Growth Hormone Optimization | CJC-1295 + Ipamorelin, Sermorelin, Tesamorelin | Strong — Tesamorelin is FDA-approved |
| Weight Management | Semaglutide, Tirzepatide, Retatrutide | FDA-approved (Sema, Tirz); Phase III (Reta) |
| Anti-Aging & Longevity | Epithalon, NAD+, MOTS-c, SS-31 | Emerging — preclinical + early clinical |
| Cognitive Enhancement | Semax, Selank, Dihexa, PE-22-28 | Moderate — Semax/Selank approved in Russia |
| Sexual Health | PT-141, Kisspeptin-10, Oxytocin | Strong — PT-141 is FDA-approved (Vyleesi) |
| Sleep Optimization | DSIP, Selank, Epithalon | Moderate preclinical; growing clinical use |
| Immune Modulation | Thymosin Alpha-1, LL-37, KPV | Strong — TA1 approved internationally |
| Skin & Aesthetics | GHK-Cu, collagen peptides, SNAP-8 | Moderate to strong — collagen has RCTs |
Common Clinical Protocols
The Healing Protocol
The most commonly prescribed peptide therapy protocol for injury recovery. BPC-157 (250–500 mcg/day SubQ) is used alone or stacked with TB-500 (750 mcg 2x/week) for 4–12 weeks. Injections are placed as close to the injury site as practical. This protocol is widely used for tendon injuries, post-surgical recovery, joint pain, and gut healing.
The GH Optimization Protocol
CJC-1295 (no DAC) + Ipamorelin is the gold standard growth hormone secretagogue stack. Typical dosing is 100–300 mcg of each, injected SubQ before bed to align with the body’s natural nighttime GH pulse. This protocol is used for body composition improvement, anti-aging, sleep quality, and recovery. Cycles typically run 3–6 months with periodic lab monitoring of IGF-1 levels.
The Weight Management Protocol
Semaglutide (weekly SubQ, titrated from 0.25mg to 2.4mg over 16–20 weeks) or Tirzepatide (weekly, titrated to 15mg) represent the most effective peptide-based weight management tools available. These FDA-approved GLP-1 receptor agonists have shown 15–22% body weight reduction in clinical trials. Newer agents like Retatrutide (triple agonist) are showing even greater efficacy in Phase III.
The Longevity Protocol
Epithalon (5–10mg/day SubQ for 10–20 days, 2–3 times per year) is the most common longevity-focused peptide, targeting telomere extension and melatonin regulation. Often combined with NAD+ IV infusions for mitochondrial support and GHK-Cu topically for skin regeneration.
Finding a Qualified Provider
The quality of your peptide therapy experience depends enormously on your provider. Here’s what to look for.
Credentials. Look for board-certified physicians (MD/DO), naturopathic doctors (ND), or nurse practitioners (NP/PA-C) with specific training in peptide therapy, functional medicine, anti-aging medicine, or regenerative medicine. Relevant certifications include those from the American Academy of Anti-Aging Medicine (A4M), the Institute for Functional Medicine (IFM), and the International Peptide Society.
Compounding pharmacy relationships. Legitimate providers source peptides exclusively from licensed 503A or 503B compounding pharmacies — not from online research chemical suppliers. Ask your provider which pharmacy they use and whether it holds current state and FDA registrations.
Lab monitoring. A good provider orders baseline and follow-up labs. For GH optimization protocols, this means IGF-1, fasting glucose, and metabolic panels. For weight management, metabolic markers and thyroid function. Any provider who prescribes peptides without lab work should raise a red flag.
Informed consent. Your provider should clearly explain which peptides are FDA-approved vs. compounded, discuss the evidence level for your specific protocol, outline potential risks, and obtain documented informed consent before prescribing.
What to Expect: Your First Protocol
Initial consultation (typically 30–60 minutes) includes a health history review, discussion of your goals, lab work orders, and a treatment plan. Most providers offer telehealth consultations for convenience.
Lab work is drawn before starting treatment — baseline hormones, metabolic panel, CBC, and specific markers depending on your protocol.
Prescription and delivery. Your provider sends the prescription to a licensed compounding pharmacy, which ships the peptide(s) directly to you, typically with reconstitution supplies (bacteriostatic water, syringes, alcohol swabs).
Self-administration. Most peptide protocols involve self-administered subcutaneous injections. Your provider’s office should walk you through the injection technique during your first visit or via video. It’s a simple process using small insulin syringes — far less intimidating than it sounds.
Follow-up. Expect check-ins at 4–6 weeks and repeat labs at 8–12 weeks to assess response and adjust dosing as needed.
Cost & Insurance
Peptide therapy costs vary significantly by peptide, provider, and whether insurance applies.
| Category | Typical Monthly Cost | Insurance |
|---|---|---|
| Collagen peptides (OTC) | $20–50 | Not covered (supplement) |
| BPC-157 / TB-500 | $150–400 | Rarely covered |
| CJC-1295 + Ipamorelin | $200–500 | Rarely covered |
| Semaglutide (compounded) | $300–500 | Sometimes covered |
| Semaglutide (brand Wegovy) | $800–1,300 | Increasingly covered |
| Initial consultation | $200–500 (one-time) | Sometimes covered |
Most compounded peptide therapies are paid out-of-pocket. FDA-approved peptides like Semaglutide, Tirzepatide, and PT-141 have better insurance coverage, though coverage varies widely by plan. Many providers offer membership or subscription models that bundle consultations, labs, and peptides at a lower total cost.
Safety & Risks
Peptide therapy safety depends on three factors: the specific peptide, the source quality, and the clinical supervision.
FDA-approved peptides (insulin, Semaglutide, PT-141) have gone through rigorous Phase III clinical trials with well-characterized safety profiles. These carry the most predictable risk-benefit profiles.
Compounded peptides (BPC-157, CJC-1295, Ipamorelin) have favorable safety data from preclinical studies and clinical use, but lack the comprehensive safety data that comes from full FDA approval. The primary risk with compounded peptides is source quality — peptides from unlicensed sources may have unknown purity, contamination, or potency issues.
Never self-prescribe peptides purchased from research chemical websites. These products are labeled “not for human use,” may contain contaminants or incorrect concentrations, and bypass all quality safeguards. Always work with a licensed provider using a licensed compounding pharmacy.
The Regulatory Landscape
Peptide regulation in the United States exists across a spectrum:
FDA-approved peptide drugs are manufactured by pharmaceutical companies under strict GMP standards and prescribed for specific approved indications. Examples: insulin, Semaglutide (Ozempic/Wegovy), Tirzepatide (Mounjaro/Zepbound), PT-141 (Vyleesi).
Compounded peptides are prepared by 503A (patient-specific) or 503B (outsourcing facility) pharmacies and prescribed by licensed physicians for off-label use. The FDA has increased scrutiny of compounded peptides since 2022, and some peptides have faced temporary restrictions. The regulatory landscape continues to evolve.
Research-use-only (RUO) peptides are sold for laboratory use only and are not legal for human administration. Purchasing and self-administering RUO peptides carries significant legal and health risks.
OTC supplements like collagen peptides are regulated as dietary supplements under DSHEA and are widely available without prescription.
Frequently Asked Questions
The medical use of specific peptides to treat or optimize health conditions. Peptides are prescribed by licensed providers, typically prepared by compounding pharmacies, and administered via injection, oral, nasal, or topical routes. Applications include healing, GH optimization, weight management, anti-aging, and cognitive enhancement.
Safety varies by peptide and source. FDA-approved peptides have rigorous safety data. Compounded peptides have favorable but less comprehensive safety profiles. The most critical safety factor is working with a qualified provider and using pharmaceutical-grade peptides from licensed pharmacies.
Ranges from $20/month for collagen supplements to $150-500/month for compounded peptides to $800-1,300/month for brand-name GLP-1 drugs. Initial consultations typically cost $200-500. Most compounded peptide therapy is paid out-of-pocket.
Look for board-certified physicians or NDs with training in peptide therapy, functional medicine, or anti-aging medicine. Verify they use licensed 503A/503B compounding pharmacies, order baseline labs, and provide informed consent. Provider directories from A4M and IFM are good starting points.